A ground-breaking clinical trial to test the safety of mesenchymal stromal cells (MSCs) in early knee osteoarthritis is now underway at Toronto Western Hospital.
Manon Casal is the newest participant to test the safety of MSCs in early knee osteoarthritis. She has been suffering from pain in her knees for longer than she can remember. “I drive a school bus for work and the pressure on my knees is so painful,” she explains.
Manon has tried every current
treatment available for her condition,
but has found little relief from the
discomfort and loss of mobility.
She began the clinical trial in
July 2015. The study will follow
her progress for five years. “If it
works, my knees will be rejuvenated,
with no pain,” Manon states.
The trial involves 12 patients
between the ages of 40 and
65 with moderate to severe
osteoarthritis in their knees.